Mucoid or alginate-producing strains of the opportunistic pathogen Pseudomoms aeruginosa frequently colonise the respiratory tract of patients with cystic fibrosis (CF). The virulence factor alginate protects the bacterium from the host immune system and aggnssive antibiotic therapies, thus causing an intractable chronic pulmonary infection which is recognised as a major cause of morbidity and mortality amongst these patients.
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Alginates are linear exopolysaccarides comprising (1 +)-linked &D-mannuronate (M) and its CS-epimer a-L-guluronate (G). These residues are arranged in block structures which may be [poly-mannuronate (poly-MM) or poly-guluronate (poly-GG)] or random heteropolymeric sequences (poly-MG). Alginate produced by P.aeruginosa lacks poly-GG blocks and the mannuronate residues may be either mono-or di-0-acetylated [l] . At present the clinical management of mucoid P. aeruginosu infections in the CF lung requires the administration of potent antibiotics and a complex regime of physiotherapy. These measures however conml the infection only transiently and the micro-organism is never totally eradicated. One suggested therapy has been the use of alginate lyases to degrade and aid the dispersal of alginate allowing the host immune system and conventional treatments an opportunity to clear the pulmonary infection [l] . In an in vitro model addition of an alginate lyase has been shown to enhance the uptake of mucoid P. aeruginosa by macrophages [2] .
Alginatc lyases have been isolated from many sources, and are generally endo-acting enzymes that catalyse the blimination of the 4-0-linked glycosidic bond of alginates with the formation of unsaturated uronic-acid-containing oligosaccharides [3] . They all have an absolute specificity for either mannuronate or guluronate residues at the non-reducing end of the bond to be cleaved [4] .
Guluronate-sptcific lyases are potentially better therapeutic agents in the treatment of mucoid P. aeruginosu infections as bacterial alginates contain 0-acetylated mannuronate residues and are therefore more resistant to degradation [2] .
The Klebsiella pneumonia guluronate-specific alginate lyase gene has been sub-cloned into pLAFX3 to produce the construct pALY8 [5, 61. In this study, 'H-nmr has been used to investigate the effects of the overexpression of the K.pneumoniae alginate lyase on alginate structure in the mucoid P. aeruginosa strain 2192. Experimental procedures have been described previously [7] .
Results (Table 1) indicate that the crude and purified extracellular material produced by both pLAFR3-and pALY8-transconjugants contained carbohydrate, uronic acid and minor quantities of protein. 73.6 f 9.9 9.7 f 6.3 1.9 f 0.9
(Results are percentages of fxeeze-dried weight).
Analysis of the purified material from pALY8-tmnsconjugants revealed that only 13% of the total carbohydrate was uronic acid, while that of the pLAFR3containing strain was 90%. This is presumably a reflection of both lyase activity and the alginate purification procedure utilised in this study which is based upon the selective precipitation of large polysaccharide molecules and extensive dialysis. K.pneumoniue a l g i~t e lyase expression in mucoid strains of P. aeruginosa caused a significant decrease in both average alginate chain length and molecular weight. This affects morphology on solid media with the appearance of non-mucoid-like colonies [6]. extracted from both pLAFR3-and pALY8-transconjugants are essentially the same, both lack poly-GG residues and comprise similar doublet frequencies and degree of 0-acetylation.
The alginate lH-nmr spectra (not shown) derived from both transconjugants contained the characteristic alginate peaks at 4.65ppm and 5.05ppm however, the spectrum from the pALY8-transconjugants also contained minor peaks at 4.90ppm and 5.2Oppm presumably these are due to the increased number of anomeric reducing-end protons as a result of lyase activity.
Previous data from this laboratory [6] indicated that the IH-nmr spectra obtained from material derived from mucoid P. aeruginosa strains FRDl and FRD130 containing pALY8 lacked the peaks characteristic of alginate. In this study, alginate has been detected in the extracellular material derived from the strain 2192containing pALY8, and the inability to detect alginate in the former study was probably related to the low amounts of material analysed. The expression of the K. pneumoniae alginate lyase gene in the mucoid P. aeruginosa strain 2192 has apparently little effect upon alginate structural properties. However, lyase expression significantly reduces alginate chain length and overall yields. This reduction in alginate molecular weight (and hence viscosity) due to alginate lyase activity may be of therapeutic value aiding the removal of mucoid P. aeruginosa infections from the CF lung.
We are grateful to the Cystic Fibrosis Research trust (UK) for financial support for this and related work.
